Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Duc, Thang Vu"'
Autor:
Truong Giang Nguyen, Assoc.Prof., MD., PhD, Ngoc Trung Nguyen, Assoc.Prof., MD., PhD, Van Nam Nguyen, Assoc.Prof., MD., PhD, Trung Kien Nguyen, Assoc.Prof., MD., PhD, Duc Thang Vu, MD., PhD, Viet Anh Le, MD., PhD
Publikováno v:
Asian Journal of Surgery, Vol 44, Iss 1, Pp 369-373 (2021)
Summary: Objectives: To investigate clinical and histopathological characteristics of Vietnamese patients with thymoma and myasthenia gravis (MG), and the outcomes of surgical management using video-assisted thoracoscopic surgery (VATS) thymectomy. M
Externí odkaz:
https://doaj.org/article/49159345c4e9473799473326b586f5a4
Autor:
Efraim, Yael, Sarig, Hadar, Cohen Anavy, Noa, Sarig, Udi, de Berardinis, Elio, Chaw, Su-Yin, Krishnamoorthi, Muthukumar, Kalifa, Jérôme, Bogireddi, Hanumakumar, Duc, Thang Vu, Kofidis, Theodoros, Baruch, Limor, Boey, Freddy Y.C., Venkatraman, Subbu S., Machluf, Marcelle
Publikováno v:
In Acta Biomaterialia 1 March 2017 50:220-233
Publikováno v:
In Optics Communications 15 April 2015 341:228-236
Publikováno v:
Lecture Notes in Civil Engineering ISBN: 9789811933028
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9de165f49fbbf06f62ab0bb680c1f08f
https://doi.org/10.1007/978-981-19-3303-5_35
https://doi.org/10.1007/978-981-19-3303-5_35
Autor:
Truong Giang Nguyen, Trung Kien Nguyen, Van Nam Nguyen, Ngoc Trung Nguyen, Viet Anh Le, Duc Thang Vu
Publikováno v:
Asian Journal of Surgery, Vol 44, Iss 1, Pp 369-373 (2021)
Summary Objectives To investigate clinical and histopathological characteristics of Vietnamese patients with thymoma and myasthenia gravis (MG), and the outcomes of surgical management using video-assisted thoracoscopic surgery (VATS) thymectomy. Met
Publikováno v:
Cardiology Research and Practice, Vol 2012 (2012)
Externí odkaz:
https://doaj.org/article/8bbaf2dacf6e4ae7ba84058f5a5b91ee
Autor:
Duc Thang Vu, Theo Kofidis
Publikováno v:
Cardiology Research and Practice, Vol 2012 (2012)
Myocardial infarction is the leading cause of death in developed countries. Cardiac cell therapy has been introduced to clinical trials for more than ten years but its results are still controversial. Tissue engineering has addressed some limitations
Externí odkaz:
https://doaj.org/article/a4510c243bbc41698ee4c568e3183911
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 143:985-988
Despite the development of mitral valve repair and percutaneous mitral procedures, mitral valve replacement (MVR) is still the first option for 62% and 43.2% to 61% of patients with mitral regurgitation and mitral stenosis, respectively. The implanta
Autor:
Jing Wang, Shera Lilyanna, Ai Li Tan, Shu Uin Gan, Lieng H. Ling, Thang T. Phan, Duc Thang Vu, Theo Kofidis, Eliana C. Martinez, Chuen N. Lee
Publikováno v:
Stem cells and development. 22(23)
A crucial question in post-ischemic cell therapy refers to the ideal method of cell delivery to the heart. We hypothesized that epicardial implantation of subamnion-cord-lining mesenchymal stem cells (CL-MSC) angiogenic spheroids embedded within fibr